Zluri

Zluri is a commercial software brand in the SaaS management and IT operations space. It is known as a SaaS management platform (SMP) that helps IT, finance and security teams discover the applications in use across an organization, manage SaaS subscriptions and licenses, automate employee onboarding and offboarding workflows, and control SaaS spend and security posture. The brand is typically positioned alongside other SaaS management and shadow-IT discovery tools, targeting mid-market and enterprise customers who need visibility into a sprawling software estate. Note on evidence: the supplied source snippet concerns Debiopharm and antibody-drug-conjugate linker technology and contains no information about Zluri. No verifiable official-site or Wikipedia evidence about Zluri was provided in this task, so this dossier is deliberately limited and makes no claims about founding year, founders, headquarters, funding, ownership, customers or specific product modules. Those fields are left empty rather than guessed. This entry should be revisited with primary sources (the Zluri official website, press releases, funding announcements or a Wikipedia article) before being treated as a complete brand record.

No verifiable history of the Zluri brand was supplied in the evidence for this task. The only source snippet provided concerns Debiopharm's antibody-drug-conjugate linker research and is unrelated to Zluri. A dated brand history (founding, funding rounds, product launches, leadership changes) should be compiled from primary sources such as the Zluri official website, company blog, press releases and investor announcements before being added here.

• 2026.10.14

  Reported2026.10.14

  Infotech completes acquisition of Zluri[2]Infotech 完成对 Zluri 的收购elliotlakestandard.ca

  On October 14, 2026, Infotech announced the completion of its acquisition of Zluri, a SaaS management and identity governance and administration provider founded in 2020, marking the first acquisition in Infotech's 30-year history. Zluri will continue serving customers while contributing Application Discovery and Identity Governance and Administration capabilities to the CIO Analytics platform. Terms of the transaction were not disclosed; Solomon Partners served as financial advisor to Infotech.

Read more

1. 1Debiopharm's Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistancefinanznachrichten.de
2. 2Infotech 完成对 Zluri 的收购elliotlakestandard.ca